O objetivo deste estudo é analisar a associação entre ansiedade e depressão durante o isolamento social da pandemia de covid-19 no Brasil. Dados de 1.053 adultos brasileiros entre 18 e 59 anos foram coletados por meio de questionário online, entre abril e maio de 2020, para este estudo transversal. Foi utilizada a Escala Hospitalar de Ansiedade e Depressão, e foram analisados fatores sociodemográficos e econômicos. Houve 37% e 20% de risco moderado e alto de ansiedade, respectivamente. Foi observada uma relação direta entre ansiedade e ser do sexo feminino (OR: 1,55; IC95%: 1,02-2,34), ser mais jovem (OR: 4,78; IC95%: 2,71-8,42, para pessoas entre 18-28 anos) e ter rendimentos mais baixos (OR: 1,51; IC95%: 1,69-1,96). Os resultados foram na mesma direção para a depressão, e, adicionalmente, foi demonstrada associação entre isolamento social (parcial ou total) e depressão (OR: 1,42; IC95%: 1,01-2,01). Este estudo encontrou uma associação entre mulheres, populações mais jovens e indivíduos de menor renda e o risco de sofrer ansiedade e depressão durante o confinamento decretado devido à pandemia de covid-19. Além disso, o isolamento social foi associado ao risco de depressão.

Objective. To assess the effectiveness of the resistance training to improve fatigue levels in people with cancer who are enrolled in adjuvant and/or neoadjuvant treatment. Methods. MEDLINE, Web of Science, Embase, SPORTDiscus, LILACS, CENTRAL, and CINAHL databases were searched from May to December 7, 2021. Randomized clinical trials (RCT) that evaluate the effects of resistance training on fatigue levels in people undergoing cancer treatment were included. The PEDro scale was considered to assess methodological quality of studies, and the evidence was summarized through the GRADE system. The standardized average differences, effect size, and inverse variance model for meta-analysis were calculated. Results. Fifteen RCT for qualitative synthesis and thirteen for meta-analysis were selected. A moderate to high level of evidence of resistance training was identified to improve fatigue in people undergoing cancer treatment. Meta-analysis showed a significant reduction in fatigue ( SMD = − 0.31 , CI   95 % = − 0.58 , -0.12, P = 0.001 ) after 10 to 35 sessions of resistance training. Conclusion. The 10 to 35 sessions of resistance training are effective in reducing fatigue level in cancer patients who are undergoing cancer treatment and have a moderate level of quality evidence.

Background. Chemotherapy-induced peripheral neuropathy is a common adverse effect of chemotherapeutic treatment and is associated with decreased quality of life. The aim of this study was to evaluate the validity and reliability of the neurotoxicity subscale of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) for the Chilean population. Methods. A cross-sectional study in which 101 participants with haematologic, colorectal, breast, gastric, gynaecological, and other types of cancer completed the FACT/GOG-Ntx. Content validity ( n = 14 health professionals evaluated the subscale in four categories: test-retest reliability ( n = 20 patients), dimensionality, internal consistency, and concurrent validity and discriminant validity. In all analyses, p < 0.05 was considered significant. Results. There was an agreement among the evaluators for all categories of the subscale (Kendall’s coefficient, W = 0.4 , p < 0.01 ) and moderate to high intrarater reliability ( intraclass   correlation   coefficient = 0.7 – 0.9 ). Of the 11 original items that make up the subscale, none was eliminated. The factor analysis generated four factors that represented 72.2% of the total variance. Cronbach’s α was 0.8 for the 11 items. Women showed greater compromise in emotional well-being and neurotoxicity symptoms compared with men, and age was directly correlated with the questions ‘I have difficulty hearing’ ( r = 0.2 , p = 0.019 ) and ‘I feel a noise or buzzing in my ears’ ( r = 0.2 , p = 0.03 ). Conclusion. The Chilean version of the FACT/GOG-Ntx neurotoxicity subscale is a valid and reliable scale for evaluating neurotoxicity symptoms in adult cancer survivors in Latin America. The scales also adequately distinguish between sex-based well-being among the afflicted population.